Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mort...
Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Background
Prostate cancer is a clinically heterogeneous disease with a subset of patients rapidly progressing to lethal‐metastatic prostate cancer. Current clinicopathological measures are imperfect predictors of disease progression. Epigenetic changes are amongst the earliest molecular changes in tumourigenesis. To find new prognostic biomarke...
Alternative Titles
Full title
Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ce0e644fc6654c8a9b89ff431e3a8d9b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ce0e644fc6654c8a9b89ff431e3a8d9b
Other Identifiers
ISSN
2001-1326
E-ISSN
2001-1326
DOI
10.1002/ctm2.1030
